BNP Paribas Exane analyst Peter Verdult initiated coverage of GSK (GSK) with a Neutral rating and $35.25 price target Stay Ahead of the Market: ...

GSK plc ( NYSE: GSK) has failed to meet key ethical and regulatory standards in how it marketed and provided prescribing information for its drug Omjjara, according to a ruling issued Tuesday by an ...

As we’ve been reporting, US Vice-President JD Vance says there is a “good chance” that the US and UK will come to a mutually ...

GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk ...

Goldman Sachs says the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices published its final agenda ...

CEO Emma Walmsley said the company has been anticipating tariffs on the industry and is “confident” the company can navigate through it, Ashleigh Furlong and Ruth David of Bloomberg reports. The U.S.

NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential ...

The FTSE 100 joined European markets back in the red on Wednesday, as investors braced for Trump’s forthcoming tariff ...

Green Bay Packers coach Matt LaFleur believes the team needs to "maximize those moments" to take the next step and reach the Super Bowl. The Packers have fielded the NFL’s youngest roster for two ...

Among those struggling is one who was a focal point of the woes last season, first baseman Matt Olson. While he’s had no trouble reaching base (.400 on-base percentage), nothing has gone right ...

The Food and Drug Administration’s top vaccine official, Peter Marks, resigned on Friday, citing what he called Health and Human Services Secretary Robert F. Kennedy Jr.’s "misinformation and ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares ...